Moreover, research focusing on patient-derived xenografts (PDX) and/or tumor organoids in humanized mice and/or transgenic mice could greatly contribute to expanding our knowledge of the intricate roles PCSK9 plays within the TIME of human malignancies. This evidence concerns the gene PCSK9 and neoplasm.